Takeaways from the Marcus Evans Evolution Summit

This May, PharmaOut attended the Marcus Evans Evolution Summit in Boston, MA. The summit brings clinical trial executives and solution providers together to discuss challenges and innovation within the industry as well as market development and new strategies to help bring products to patients in need. At PharmaOut, we provide staffing and consulting services for our clients.

Continue Reading

Cures Act

Over the last two years the COVID-19 pandemic has forced us to change nearly every aspect of our daily routines in both our personal and professional lives. In the healthcare space we have been further challenged to find a treatment option to combat COVID-19 as quickly as possible. Members of the FDA had to rely

Continue Reading

Returning to the Office Post COVID Vaccine  

Pfizer, Moderna and J&J collectively spearheaded the availability of the COVID-19 vaccine to Americans desperately awaiting a chance to return to normal life. While a number of the US population remains unvaccinated, companies have begun to implement a return to the office policy after more than a year of remote work. Many offices have already

Continue Reading

Artificial Intelligence in the Pharma Industry: Discovery

Artificial intelligence has played an increasingly important role in many industries when developing new, cutting edge technologies. With the recent pandemic, both the pharmaceutical and biotech industries have had to utilize more technology than ever before in order to meet the increased demand for vaccines. By streamlining research, production and clinical trials, AI has helped

Continue Reading

Clinical Trials Post COVID – Takeaways from the Marcus Evans Evolution Summit

This March PharmaOut attended the Marcus Evans Evolution Summit, an entirely virtual event that brought together pharmaceutical and biotech executives to collaborate and share changes within the industry. The Marcus Evans team did an excellent job of making this virtual event both interactive and informative. A common theme of the presentations were Clinical Trials Post COVID. Leading industry experts shared

Continue Reading